medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2006, Number 1

<< Back Next >>

Rev Mex Urol 2006; 66 (1)

Cistectomía total en tumores de vejiga

García GA, Ponce de León BF, Matos LE, Cruz AM, Pedro SIE, Bautista MJT, Sala RJC, Capdevila VD

Language: Spanish
References: 13
Page: 12-16
PDF size: 218.05 Kb.


ABSTRACT

Bladder cancer is the second most common cancer of the genitourinary tract. Once established the diagnosisit has to being marked the staging of the illness with the purpose of clarifying the therapeutic modality, prognostic, quality of life and survival. The objective of this work it was to evaluate the results of the total cystectomy in the treatment of the bladder cancer, carrying out a descriptive study that included 94 patients with bladder cancer, invasive in 76 of them and in its majority in a high degree, multiple, recurrent and bigger than 2 cm. We concluded that is an appropriate treatment for the control of the cancer in early stages.


REFERENCES

  1. Tanagho EA, Aninch JW. Urología general de Smith, 12a edición. 2001. p. 357-369.

  2. Nano Valenzuela M, Muñoz Reyes J, García Pérez V. Inmunoterapia intravesical con BCG en el carcinoma superficial de células transicionales de la vejiga. Rev Col Mex Urología. 1994;11:203.

  3. Rodríguez JM, Mayayo T, Busgo J, Escudero A. Nuevo protocolo de estadiaje local en el carcinoma vesical. Correlación ultrasonográfica, citológica e histopatológica. Archivos Españoles de Urología. 1990 sept;43 (1):51-64.

  4. Walsh, Retik, Vaughan, OEIN, Campbell's Urology 8th edition, 2002;Vol. 4(77):2785-2841.

  5. Tkachuk et al. The surgical treatment of patients with bladder cancer in middle and old age. Urol-Nefro- Mock. 1997 Jan-Feb;(1):23-25.

  6. González C, Ludava JM, Roncales A. Cistectomía radical en el tratamiento del carcinoma vesical infiltrante. Análisis de 15 años. Arch Esp Urología. 1991;44:395-402.

  7. Torres-Roca JF. Protocolo de preservación vesical en el tratamiento del cáncer vesical del músculo invasor. Cancer control. Journal of the Moffitt Cancer Center. 2004 Nov-Dec;11(6):358-363.

  8. Hughes ODM, Perkins AC, Frier M, Wastie ML, Denton G, Price MR, Denley H, Bishop MC. Imaging for staging bladder cancer a clinical study of intravenous 111indium-labelled anti-MUC1 mucin monoclonal antibody C595. January 2001; Vol 87 Issue 1:1-130.

  9. Zieger K, Wolf H, Olsen PR, Hojgaard K. Long-term follow-up of noninvasive bladder tumours(stage Ta): recurrence and progression. 2000 May; Vol 85 Issue 7:783-975.

  10. Leissner J, Hohenfellner R, Thüroff JW, Wolf HK. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder significance for staging and prognosis. 2000 May; Vol 85 Issue 7:976-1020.

  11. Mansson A, Caruso A, Capovilla E, Colleen S, Bassi P, Pagano F, Mansson W. Quality of life after radical cystectomy and orthotopic bladder substitution: a comparison between Italian and Swedish men. 2000 January; Vol 85 Issue 1:8-169.

  12. Rosario DJ, Becker M, Anderson JB. The changing pattern of mortality and morbidity from radical cystectomy. 2000 March; Vol 85 Issue 4:389-577.

  13. Yiou R, Patard JJ, Benhard H, Abbou CC, Chopin DK. Outcome of radical cystectomy for bladder cancer according to the disease type at presentation. 2002 March; Vol 89 Issue 4:327- 465.




2020     |     www.medigraphic.com